Ingrid Vášová

1.5k total citations
35 papers, 293 citations indexed

About

Ingrid Vášová is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Ingrid Vášová has authored 35 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 15 papers in Oncology and 9 papers in Genetics. Recurrent topics in Ingrid Vášová's work include Lymphoma Diagnosis and Treatment (18 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Lung Cancer Treatments and Mutations (9 papers). Ingrid Vášová is often cited by papers focused on Lymphoma Diagnosis and Treatment (18 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Lung Cancer Treatments and Mutations (9 papers). Ingrid Vášová collaborates with scholars based in Czechia, Germany and Sweden. Ingrid Vášová's co-authors include Max Wolf, Michael Pfreundschuh, Jiří Vorlíček, Walter Mingrone, Evelyn Kuhnt, Anthony D. Ho, Eva Cavallin‐Ståhl, Adriana Scheliga, Markus Loeffler and Ruth Pettengell and has published in prestigious journals such as Blood, The Lancet Oncology and Bone Marrow Transplantation.

In The Last Decade

Ingrid Vášová

29 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingrid Vášová Czechia 7 192 153 78 59 35 35 293
Annalisa Gabriele Italy 8 255 1.3× 112 0.7× 87 1.1× 88 1.5× 58 1.7× 12 315
Lenka Šmardová Czechia 9 256 1.3× 220 1.4× 125 1.6× 42 0.7× 108 3.1× 28 407
Cristina Becchimanzi Italy 8 168 0.9× 111 0.7× 71 0.9× 72 1.2× 18 0.5× 19 232
Gianpaolo Marcacci Italy 8 192 1.0× 115 0.8× 71 0.9× 129 2.2× 32 0.9× 17 313
Jean‐Pierre Vilque France 10 72 0.4× 126 0.8× 20 0.3× 45 0.8× 28 0.8× 18 254
Rosa Ruchlemer United Kingdom 6 240 1.3× 85 0.6× 38 0.5× 135 2.3× 39 1.1× 8 291
Sara Steffanoni Italy 7 176 0.9× 72 0.5× 114 1.5× 82 1.4× 26 0.7× 26 265
Zdravko Mitrović Croatia 10 160 0.8× 117 0.8× 29 0.4× 95 1.6× 20 0.6× 30 255
F. Pagliai Italy 8 167 0.9× 62 0.4× 35 0.4× 32 0.5× 37 1.1× 11 284
Annalisa Arcari Italy 11 159 0.8× 166 1.1× 57 0.7× 69 1.2× 12 0.3× 24 272

Countries citing papers authored by Ingrid Vášová

Since Specialization
Citations

This map shows the geographic impact of Ingrid Vášová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Vášová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Vášová more than expected).

Fields of papers citing papers by Ingrid Vášová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid Vášová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Vášová. The network helps show where Ingrid Vášová may publish in the future.

Co-authorship network of co-authors of Ingrid Vášová

This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid Vášová. A scholar is included among the top collaborators of Ingrid Vášová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid Vášová. Ingrid Vášová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Winkler, Julia, Andreá Schneider, Andreas Mayr, et al.. (2020). Measuring the cellular memory B cell response after vaccination in patients after allogeneic stem cell transplantation. Annals of Hematology. 99(8). 1895–1906. 10 indexed citations
2.
Pytlík, Robert, David Belada, Kateřina Kubáčková, et al.. (2014). Treatment of high-risk aggressive B-cell non-Hodgkin lymphomas with rituximab, intensive induction and high-dose consolidation: long-term analysis of the R-MegaCHOP-ESHAP-BEAM Trial. Leukemia & lymphoma. 56(1). 57–64. 1 indexed citations
3.
Janíková, Andrea, Boris Tichý, Kateřina Staňo Kozubík, et al.. (2010). Gene expression profiling in follicular lymphoma and its implication for clinical practice. Leukemia & lymphoma. 52(1). 59–68. 7 indexed citations
4.
Janíková, Andrea, Zdeněk Kořı́stek, Tomáš Pavlík, et al.. (2009). Efficacious but insidious: A retrospective analysis of fludarabine-induced myelotoxicity using long-term culture–initiating cells in 100 follicular lymphoma patients. Experimental Hematology. 37(11). 1266–1273. 7 indexed citations
5.
Janíková, Andrea, Jiřı́ Mayer, Leoš Křen, et al.. (2009). The persistence of t(14;18)-bearing cells in lymph nodes of patients with follicular lymphoma in complete remission: the evidence for ‘a lymphoma stem cell’. Leukemia & lymphoma. 50(7). 1102–1109. 6 indexed citations
6.
Papajík, Tomáš, Marek Trněný, Ingrid Vášová, et al.. (2009). Epidemiologie ne-hodgkinových lymfomů v České republice, Evropě a Severní Americe. 3(3). 141–146. 1 indexed citations
7.
8.
Šmardová, Lenka, Ingrid Vášová, Milan Navrátil, et al.. (2008). Burkittův lymfom: přehled patofyziologie, diagnostiky a terapie.
9.
Elbl, Lubomı́r, et al.. (2007). [Chronic fatigue syndrome in cancer patients. Diagnostic and treatment options].. PubMed. 53(9). 979–85. 1 indexed citations
10.
Elbl, Lubomı́r, Ingrid Vášová, Zdeněk Král, et al.. (2006). Cardiopulmonary exercise testing in the evaluation of functional capacity after treatment of lymphomas in adults. Leukemia & lymphoma. 47(5). 843–851. 30 indexed citations
11.
Elbl, Lubomı́r, et al.. (2006). [Comparison of plasmatic levels of B-natriuretic peptide with echocardiographic indicators of left ventricle function after doxorubicin therapy].. PubMed. 52(6). 563–70. 5 indexed citations
12.
Pytlík, Robert, Marek Trněný, David Belada, et al.. (2005). Treatment of High Risk Diffuse Large B-Cell Lymphomas (DLBCL) with Ntensive Induction Chemotherapy, Rituximab and Autologous Stem Cell Transplant.. Blood. 106(11). 1506–1506. 1 indexed citations
13.
14.
Mayer, Jiřı́, Ingrid Vášová, Zdeněk Kořı́stek, et al.. (2001). Ifosfamide- and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma.. PubMed. 64. 21–7. 6 indexed citations
15.
Konečný, M, et al.. (2000). Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.. PubMed. 47(2). 129–32. 1 indexed citations
16.
Mayer, Jiřı́, Zdeněk Kořı́stek, Ingrid Vášová, Jiří Vorlíček, & P Vodvářka. (1999). Ifosfamide and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma. Bone Marrow Transplantation. 23(5). 413–419. 13 indexed citations
17.
Elbl, Lubomı́r, et al.. (1998). Anthracyclines and the heart.. 7(4). 1 indexed citations
18.
Penka, Miroslav, et al.. (1998). Herpes simplex infection as possible etiology for febrile neutropenia and mucositis in patients treated for hematological malignancies.. PubMed. 25(2). 57–60. 4 indexed citations
19.
Mayer, Jiřı́, Zdeněk Kořı́stek, Ingrid Vášová, et al.. (1998). [Chemotherapy of resistant and recurrent lymphoma based on a combination of ifosfamide and etoposide. Antitumor effects, toxicity and stimulation of peripheral stem cells].. PubMed. 137(19). 590–7. 1 indexed citations
20.
Hájek, Roman, Zdeněk Adam, Ingrid Vášová, & Zdeněk Král. (1996). Evolution of multiple myeloma treatment from melphalan monotherapy to bone marrow transplantation.. PubMed. 23(3). 85–91. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annalisa Gabriele Breakdown of academic impact, for papers by Lenka Šmardová Breakdown of academic impact, for papers by Cristina Becchimanzi Breakdown of academic impact, for papers by Gianpaolo Marcacci Breakdown of academic impact, for papers by Jean‐Pierre Vilque Breakdown of academic impact, for papers by Rosa Ruchlemer Breakdown of academic impact, for papers by Sara Steffanoni Breakdown of academic impact, for papers by Zdravko Mitrović Breakdown of academic impact, for papers by F. Pagliai Breakdown of academic impact, for papers by Annalisa Arcari
Rankless by CCL
2026